Paul Smaltz, vice president, pharmaceuticals, at Roquette, explores how taking a more ‘human’ look at the issue of drug shortages and supply chain resilience could help the industry find the fresh ideas it needs to tackle this pressing problem.
Paul Smaltz, vice president, pharmaceuticals, at Roquette, explores how taking a more ‘human’ look at the issue of drug shortages and supply chain resilience could help the industry find the fresh ideas it needs to tackle this increasingly pressing problem.
AsiaVision Getty Images
The week's biggest stories from this industry, direct to your inbox.
